| 2024-04-02 11:36 | CC:APLI | Appili Therapeutics Inc | 0.035 | News Release200 | Appili Therapeutics to be acquired by Aditxt |
| 2024-03-12 10:04 | CC:APLI | Appili Therapeutics Inc | 0.035 | News Release200 | Appili researcher publishes manuscript on tularemia |
| 2024-02-13 22:18 | CC:APLI | Appili Therapeutics Inc | 0.025 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-02-13 22:13 | CC:APLI | Appili Therapeutics Inc | 0.025 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-02-13 17:57 | CC:APLI | Appili Therapeutics Inc | 0.025 | News Release200 | Appili has Dec. 31 cash position of $600,000 |
| 2023-12-15 10:13 | CC:APLI | Appili Therapeutics Inc | 0.04 | News Release200 | Appili Therapeutics partner receives ATI-1701 patent |
| 2023-11-14 15:57 | CC:APLI | Appili Therapeutics Inc | 0.035 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-11-14 15:55 | CC:APLI | Appili Therapeutics Inc | 0.035 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-11-13 16:46 | CC:APLI | Appili Therapeutics Inc | 0.035 | News Release200 | Appili has Sept. 30 cash position of $400,000 |
| 2023-10-25 10:08 | CC:APLI | Appili Therapeutics Inc | 0.035 | News Release200 | Appili to receive further funding for ATI-1701 |
| 2023-09-27 19:27 | CC:APLI | Appili Therapeutics Inc | 0.055 | News Release200 | Appili shareholders approve all matters at AGM |
| 2023-09-25 10:30 | CC:APLI | Appili Therapeutics Inc | 0.065 | News Release200 | Appili partner receives U.S. FDA OK for ATI-1501 |
| 2023-08-11 18:30 | CC:APLI | Appili Therapeutics Inc | 0.045 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-08-11 17:01 | CC:APLI | Appili Therapeutics Inc | 0.045 | News Release200 | Appili Therapeutics has cash of $500,000 at June 30 |
| 2023-06-29 12:46 | CC:APLI | Appili Therapeutics Inc | 0.04 | News Release200 | Appili Therapeutics arranges $300,000 bridge loan |
| 2023-06-23 10:28 | CC:APLI | Appili Therapeutics Inc | 0.035 | News Release200 | Appili has cash of $2.5-million at end of fiscal 2023 |
| 2023-06-23 09:14 | CC:APLI | Appili Therapeutics Inc | 0.035 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
| 2023-06-23 08:54 | CC:APLI | Appili Therapeutics Inc | 0.035 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2023-06-23 08:05 | CC:APLI | Appili Therapeutics Inc | 0.035 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-05-24 10:05 | CC:APLI | Appili Therapeutics Inc | 0.04 | News Release200 | Appili Therapeutics receives U.S. patent for ATI-1501 |
| 2023-05-08 10:21 | CC:APLI | Appili Therapeutics Inc | 0.035 | News Release200 | Appili secures contract for ATI-1701 funding from USADA |